VIA
Virtus Investment Advisers Portfolio holdings
AUM
$296M
1-Year Return
31.42%
This Quarter Return
-1.68%
1 Year Return
+31.42%
3 Year Return
+126.24%
5 Year Return
–
10 Year Return
–
AUM
$368M
AUM Growth
+$240M
(+188%)
Cap. Flow
+$236M
Cap. Flow
% of AUM
64.25%
Top 10 Holdings %
Top 10 Hldgs %
25.49%
Holding
777
New
414
Increased
42
Reduced
13
Closed
237
Top Buys
| 1 |
Virtus Newfleet ABS/MBS ETF
VABS
|
$32.2M |
| 2 |
Virtus Newfleet Short Duration High Yield Bond ETF
VSHY
|
$24.6M |
| 3 |
Virtus SEIX Senior Loan ETF
SEIX
|
$19M |
| 4 |
SMC
Summit Midstream Corporation
SMC
|
$3.67M |
| 5 |
OCCI
OFS Credit Co
OCCI
|
$2.41M |
Top Sells
| 1 |
ICICI Bank
IBN
|
$3.75M |
| 2 |
Virtus Duff & Phelps Clean Energy ETF
VCLN
|
$2.74M |
| 3 |
Apple
AAPL
|
$2.06M |
| 4 |
Microsoft
MSFT
|
$2.02M |
| 5 |
Primoris Services
PRIM
|
$1.86M |
Sector Composition
| 1 | Financials | 24.48% |
| 2 | Healthcare | 11.95% |
| 3 | Technology | 8.6% |
| 4 | Industrials | 8.02% |
| 5 | Energy | 4.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Moderna
MRNA
$9.78B
| $238K | 0.06% |
+8,385
| New | +$238K |
|
252
Akero Therapeutics
AKRO
$3.58B
| $229K | 0.06% |
+5,654
| New | +$229K |
|
253
Day One Biopharmaceuticals
DAWN
$773M
| $222K | 0.06% |
+28,030
| New | +$222K |
|
254
Liquidia Corp
LQDA
$2.48B
| $220K | 0.06% |
+14,910
| New | +$220K |
|
255
Mineralys Therapeutics
MLYS
$2.7B
| $214K | 0.06% |
+13,494
| New | +$214K |
|
|
VRN
256
DELISTED
Veren
VRN
| $213K | 0.06% |
+32,167
| New | +$213K |
|
257
Arcutis Biotherapeutics
ARQT
$2.06B
| $210K | 0.06% |
+13,401
| New | +$210K |
|
258
Ecopetrol
EC
$18.7B
| $205K | 0.06% |
+19,620
| New | +$205K |
|
259
AnaptysBio
ANAB
$613M
| $203K | 0.06% |
+10,926
| New | +$203K |
|
260
Esperion Therapeutics
ESPR
$540M
| $203K | 0.06% |
+140,800
| New | +$203K |
|
261
Lexicon Pharmaceuticals
LXRX
$396M
| $201K | 0.05% |
+436,672
| New | +$201K |
|
262
Protagonist Therapeutics
PTGX
$3.77B
| $197K | 0.05% |
+4,065
| New | +$197K |
|
263
TIM SA
TIMB
$10.3B
| $192K | 0.05% |
+12,257
| New | +$192K |
|
264
Cheniere Energy
CQP
$26.1B
| $190K | 0.05% |
+2,871
| New | +$190K |
|
265
Sarepta Therapeutics
SRPT
$1.96B
| $184K | 0.05% |
+2,883
| New | +$184K |
|
266
Ituran Location and Control
ITRN
$672M
| $182K | 0.05% |
+5,020
| New | +$182K |
|
267
EPR Properties
EPR
$4.05B
| $181K | 0.05% |
+3,439
| New | +$181K |
|
268
Equinor
EQNR
$60.1B
| $178K | 0.05% |
+6,725
| New | +$178K |
|
269
American Tower
AMT
$92.9B
| $178K | 0.05% |
+816
| New | +$178K |
|
270
Summit Therapeutics
SMMT
$19.3B
| $177K | 0.05% |
+9,192
| New | +$177K |
|
271
Plains All American Pipeline
PAA
$12.1B
| $177K | 0.05% |
+8,849
| New | +$177K |
|
272
American Electric Power
AEP
$57.8B
| $177K | 0.05% |
+1,616
| New | +$177K |
|
273
Ryerson Holding
RYI
$757M
| $176K | 0.05% |
+7,671
| New | +$176K |
|
274
Plains GP Holdings
PAGP
$3.64B
| $176K | 0.05% |
+8,236
| New | +$176K |
|
|
EXE
275
Expand Energy Corporation Common Stock
EXE
$22.7B
| $176K | 0.05% |
+1,580
| New | +$176K |
|